AUA 2014 - Prostate Cancer - Results from #20

Viewing 21-40 of 59 articles

#AUA14 - Targeted magnetic resonance imaging/ultrasound fusion biopsy is a significantly better predictor of total prostate cancer tumor volume than random 12-core biopsy - Session Highlights

#AUA14 - Further characterization of the effects of prior or no prior docetaxel therapy on CRPC patients with bone metastases receiving Ra-223 in the phase 3 ALSYMPCA trial - Session Highlights

#AUA14 - Treatment practice patterns in metastatic castration-resistant prostate cancer patients prior to receiving sipuleucel-T: Data from PROCEED - Session Highlights

#AUA14 - State-of-the-Art Lecture: Evidence-based vs consensus-based guidelines on PSA: What are the differences and why? One vs the other? - Session Highlights

#AUA14 - State-of-the-Art Lecture: Use of positron emission tomography in advanced prostate cancer - Session Highlights

#AUA14 - Mortality benefit of screening men with a family history of prostate cancer as a surrogate for high genetic risk in the PLCO Trial - Session Highlights

#AUA14 - Prostate cancer outcomes after primary therapy in renal transplant patients - Session Highlights

#AUA14 - Performance of multiparametric MRI for high grade prostate cancer: Correlation with whole-mount pathology - Session Highlights

#AUA14 - Multiparametric MRI for detection of radio-recurrent prostate cancer: What constitutes an optimal dataset? - Session Highlights

#AUA14 - External beam radiation therapy versus high-intensity focused ultrasound for localized prostate cancer: A matched pair comparison - Session Highlights

#AUA14 - Magnetic resonance imaging/ultrasound fusion-guided biopsy for re-targeting of atypical small acinar proliferation - Session Highlights

#AUA14 - Comparison of the Prostate Cancer Prevention Trial (PCPT) risk calculator and magnetic resonance imaging in selecting men for prostate biopsies - Session Highlights

#AUA14 - Multiparametric magnetic resonance imaging and MRI/ultrasound fusion-guided biopsy stratify patients at risk for extracapsular extension at radical prostatectomy - Session Highlights

#AUA14 - Characterizing the dominant/index lesion in prostate cancer: Implications for grading and staging - Session Highlights

#AUA14 - Longitudinal analysis of PSA doubling time following radical prostatectomy (RP) - Session Highlights

#AUA14 - Early detection of prostate cancer recurrence following radical prostatectomy: The role of 18F-choline PET/CT - Session Highlights

#AUA14 - Gleason score 6 prostate cancer and presence of pathological stage T3 disease - Session Highlights

#AUA14 - Comparison of toxicity between single modality radiation therapy and combined modality radiation therapy among low-risk prostate cancer patients - Session Highlights

#AUA14 - Cryo Online Data Registry Outcomes: Minimum five year follow up data - Session Highlights

#AUA14 - Invasion of prostatic capsule: Can preoperative mp-MRI predict the information of pathological analysis - Session Highlights

1
2
3